Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Formoterol fumarate dihydrate 5microgram + mometasone furoate 200microgram inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
|
Formoterol fumarate dihydrate 5microgram + mometasone furoate 100microgram inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
|
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
3 |
Ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
3 |
Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |
Fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/actuation pressurized suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate dihydrate (substance) |
Inferred relationship |
Some |
2 |